Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · IEX Real-Time Price · USD
42.73
+1.06 (2.54%)
At close: Jul 19, 2024, 4:00 PM
42.72
-0.01 (-0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Xenon Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
259
Market Cap
3.22B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 9.43M | -9.00M | -48.83% |
Dec 31, 2021 | 18.44M | -13.73M | -42.68% |
Dec 31, 2020 | 32.17M | 25.34M | 371.02% |
Dec 31, 2019 | 6.83M | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 311.00K | -1.49M | -82.75% |
Dec 31, 2016 | 1.80M | -13.77M | -88.43% |
Dec 31, 2015 | 15.58M | -12.79M | -45.09% |
Dec 31, 2014 | 28.37M | 1.01M | 3.71% |
Dec 31, 2013 | 27.36M | 13.05M | 91.19% |
Dec 31, 2012 | 14.31M | 7.39M | 106.82% |
Dec 31, 2011 | 6.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amedisys | 2.25B |
HUTCHMED (China) | 838.00M |
GoodRx Holdings | 764.16M |
Inari Medical | 520.66M |
Axonics | 387.14M |
TG Therapeutics | 289.33M |
Twist Bioscience | 277.49M |
Arcellx | 131.66M |
XENE News
- 6 weeks ago - Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 - GlobeNewsWire
- 2 months ago - Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 3 months ago - Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting - GlobeNewsWire